Viewing Study NCT06567366


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-07-17 @ 8:42 AM
Study NCT ID: NCT06567366
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-22
First Post: 2024-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
Sponsor: Ruijin Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Large B-cell Lymphoma View
Keywords: